Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program

Blood (2024) 144 (Supplement 1): 6588.

https://doi.org/10.1182/blood-2024-202019

Published: 2024

Journal Articles

Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database

Phillip Scheinberg, Tim H. H. Brummendorf, Regis Peffault De Latour, Carlo Dufour, Raj Gokani, Morag Griffin, Juliana Hey-Hadavi, Yoshinobu Kanda, Eric Mitchell, Barbara Możejko-Pastewka, Andres Quintero, Patryk Skowron, Meltem Kurt Yüksel, Alicia Rovó

Blood (2024) 144 (Supplement 1): 2329.

https://doi.org/10.1182/blood-2024-204908

Published: 2024

Journal Articles

Lifestyle Behaviors and Health-Related Quality of Life in Long-Term Survivors of Acute Myeloid Leukemia: An International Survivorship Study By the Gimema, EORTC Quality of Life and Leukemia Groups

Blood (2023) 142 (Supplement 1): 3801.

https://doi.org/10.1182/blood-2023-179248

Published: 2023

Journal Articles

Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

Derya Koyun, Uğur Şahin, Güldane Cengiz Seval, Deniz Gören Şahin, Ayla Gökmen, Sinem Civriz Bozdağ, Selami Kocak Toprak, Pervin Topçuoğlu, Meltem Kurt Yüksel, Önder Arslan, Taner Demirer, Günhan Gürman, Osman İlhan, Meral Beksac, Muhit Özcan, Mutlu Arat

Blood (2023) 142 (Supplement 1): 3617.

https://doi.org/10.1182/blood-2023-182741

Published: 2023

Journal Articles

The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

Derya Koyun, Guldane Cengiz, Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topçuoğlu, Muhit Özcan, Onder Arslan, Taner Demirer, Osman İlhan, Gunhan Gurman, Meral Beksac, Meltem Kurt Yuksel

Blood (2022) 140 (Supplement 1): 12673–12674.

https://doi.org/10.1182/blood-2022-155998

Published: 2022

Journal Articles

Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

Hulya Yilmaz, Guldane Cengiz, Bulent Karakaya, Gul Yavuz, Merve Aydogan, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topçuoğlu, Onder Arslan, Muhit Ozcan, Osman Ilhan, Meral Beksac

Blood (2022) 140 (Supplement 1): 4369–4370.

https://doi.org/10.1182/blood-2022-170132

Published: 2022

Journal Articles

An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

Blood (2021) 138 (Supplement 1): 4730.

https://doi.org/10.1182/blood-2021-150175

Published: 2021

Journal Articles

The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Osman Ilhan, Guldane Cengiz Seval, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Muhit Özcan, Taner Demirer, Gunhan Gurman, Meral Beksac

Blood (2021) 138 (Supplement 1): 4906.

https://doi.org/10.1182/blood-2021-153905

Published: 2021

Journal Articles

Comparison of Salvage Autologous Hematopoietic Cell Transplantation with Outcomes Following Selinexor Combinations Among Double/Triple Refractory Myeloma Patients

Guldane Cengiz, Bulent Karakaya, Hulya Yilmaz, Derya Koyun, Ekin Kircali, Sevgi Basboga, Selami Kocak Toprak, Sinem Civriz Bozdag, Meltem Kurt Yuksel, Pervin Topcuoglu, Gunhan Gurman, Trinayan Kashyap, James Niblock, Meral Beksac

Blood (2021) 138 (Supplement 1): 4904.

https://doi.org/10.1182/blood-2021-148835

Published: 2021

Journal Articles

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Guldane Cengiz Seval, Nergis Ozturk, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Selami Kocak Toprak, MD

Blood (2019) 134 (Supplement_1): 4504.

https://doi.org/10.1182/blood-2019-127651

Published: 2019

Journal Articles

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Guldane Cengiz Seval, Atilla Uslu, MD, Ekin Kircali, Sinem Civriz Bozdag, MD, Klara Dalva, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Isinsu Kuzu, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2019) 134 (Supplement_1): 2019.

https://doi.org/10.1182/blood-2019-128750

Published: 2019

Journal Articles

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Ekin Kircali, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Pervin Topcuoglu, MD

Blood (2019) 134 (Supplement_1): 4156.

https://doi.org/10.1182/blood-2019-127622

Published: 2019

Journal Articles

Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

Guldane Cengiz Seval, Bahar Ulas, Onur Tascı, Fulya Ozel, MD, Buğu Bulat, Isinsu Kuzu, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Muhit Özcan, Meral Beksac, MD, Osman Ilhan, MD, Gunhan Gurman, Onder Arslan

Blood (2018) 132 (Supplement 1): 5331.

https://doi.org/10.1182/blood-2018-99-120370

Published: 2018

Journal Articles

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Erden Atilla, MD, Pervin Topcuoglu, MD, Erman Akkus, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Taner Demirer, MD, Muhit Özcan, Meral Beksac, MD, Osman Ilhan, MD, Hamdi Akan, MD, Onder Arslan, MD, Gunhan Gurman, MD, Selami Kocak Toprak, MD

Blood (2018) 132 (Supplement 1): 3472.

https://doi.org/10.1182/blood-2018-99-118314

Published: 2018

Journal Articles

Evaluation of Elderly Patients with Hematological Malignancies By Two Different Geriatric Risk Scoring Systems: G8 and Flemish Version of the Triage Risk Screening Tool (fTRST)

Erden Atilla, MD, Merih Yalciner, MD, Ozlem Kilic, RN, Nurhayat Muftuoglu, RN, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Muhit Özcan, Gunhan Gurman, MD, Osman Ilhan, MD

Blood (2018) 132 (Supplement 1): 5902.

https://doi.org/10.1182/blood-2018-99-118275

Published: 2018

Journal Articles

Is the End Close for the Graft-Versus-Host Disease That Is a Big Problem Following Allogeneic Hematopoetic Stem Cell Transplantation?

Osman Ilhan, MD, Guldane Cengiz Seval, Zubeyde Nur Ozkurt, Ali Ugur Ural, MD, Meltem Ayli, Omur Gokmen Sevindik, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Zafer Gulbas, MD, Muhit Özcan

Blood (2018) 132 (Supplement 1): 5729.

https://doi.org/10.1182/blood-2018-99-112339

Published: 2018

Journal Articles

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Pervin Topcuoglu, MD, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Klara Dalva, MD, Onder Arslan, MD, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2018) 132 (Supplement 1): 5776.

https://doi.org/10.1182/blood-2018-99-120166

Published: 2018

Journal Articles

Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Gunhan Gurman, MD, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Meral Beksac, MD, Hamdi Akan, MD

Blood (2018) 132 (Supplement 1): 4673.

https://doi.org/10.1182/blood-2018-99-120202

Published: 2018

Journal Articles

Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

Gunhan Gurman, MD, Gozde Aydemir Guloksuz, MD, Erden Atilla, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD

Blood (2016) 128 (22): 5757.

https://doi.org/10.1182/blood.V128.22.5757.5757

Published: 2016

Journal Articles

Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Osman Ilhan, MD, Erden Atilla, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD, Taner Demirer, MD, Meral Beksac, MD, Onder Arslan, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2016) 128 (22): 4939.

https://doi.org/10.1182/blood.V128.22.4939.4939

Published: 2016

NARROW

Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program

Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database

Lifestyle Behaviors and Health-Related Quality of Life in Long-Term Survivors of Acute Myeloid Leukemia: An International Survivorship Study By the Gimema, EORTC Quality of Life and Leukemia Groups

Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Comparison of Salvage Autologous Hematopoietic Cell Transplantation with Outcomes Following Selinexor Combinations Among Double/Triple Refractory Myeloma Patients

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Evaluation of Elderly Patients with Hematological Malignancies By Two Different Geriatric Risk Scoring Systems: G8 and Flemish Version of the Triage Risk Screening Tool (fTRST)

Is the End Close for the Graft-Versus-Host Disease That Is a Big Problem Following Allogeneic Hematopoetic Stem Cell Transplantation?

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only